Free Trial

Aurora Cannabis Q3 2024 Earnings Report

Aurora Cannabis logo
C$5.28 -0.27 (-4.86%)
As of 01/31/2025 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
-C$0.20
Consensus EPS
-C$0.10
Beat/Miss
Missed by -C$0.10
One Year Ago EPS
N/A

Aurora Cannabis Revenue Results

Actual Revenue
$72.61 million
Expected Revenue
$63.50 million
Beat/Miss
Beat by +$9.11 million
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Q3 2024
Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Aurora Cannabis announces corporate update
Starting 2025 Strong: 2 AI Stocks Under $10 You Can’t Miss
As we step into 2025, artificial intelligence (AI) continues to revolutionize industries with groundbreaking advancements. From the surge in generative AI technologies transforming creative processes to AI-driven automation enhancing operational efficiencies, the landscape is brimming with innovation. These rapid developments are creating lucrative opportunities for investors who recognize the potential of emerging AI companies.
Aurora Cannabis (ACB) Receives a Hold from ATB Capital Markets
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile

More Earnings Resources from MarketBeat